AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmakodynamics of AZD2820 After Multiple Ascending Doses
- First Posted Date
- 2011-11-10
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 18
- Registration Number
- NCT01469923
- Locations
- 🇬🇧
Research site, London, United Kingdom
Efficacy and Safety of Aclidinium Bromide 400 µg Compared to Placebo and to Tiotropium Bromide in Patients With Stable Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- First Posted Date
- 2011-11-01
- Last Posted Date
- 2017-01-04
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 414
- Registration Number
- NCT01462929
- Locations
- 🇵🇱
Almirall Investigational Site #14, Tarnow, Poland
🇵🇱Almirall Investigational Site #17, Krakow, Poland
🇩🇪Almirall Investigational Site #9, Frankfurt, Germany
Long-term Efficacy and Safety of Aclidinium Bromide/Formoterol Fumarate Fixed-Dose Combination
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- First Posted Date
- 2011-11-01
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2443
- Registration Number
- NCT01462942
- Locations
- 🇺🇦
Almirall Investigational Site #9, Donetsk, Ukraine
🇬🇧Almirall Investigational Site #8, Manchester, United Kingdom
🇬🇧Almirall Investigational Site #1, London, United Kingdom
Study in Healthy Subjects to Measure the Effects of Food on the Pharmacokinetics of TC-5214
- First Posted Date
- 2011-10-25
- Last Posted Date
- 2012-01-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 18
- Registration Number
- NCT01458899
- Locations
- 🇺🇸
Research Site, Overland Park, Kansas, United States
To Assess the Effect of Administration of 2 Formulation of AZD3241 on Blood Concentration in Healthy Volunteers
- Conditions
- Parkinson's Disease
- Interventions
- Drug: AZD3241 ER formulation 1Drug: PlaceboDrug: AZD3241 Alternative titration scheme with formulation 1 or 2
- First Posted Date
- 2011-10-24
- Last Posted Date
- 2012-08-17
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT01457807
- Locations
- 🇬🇧
Research site, London, United Kingdom
Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer
- Conditions
- Gastro-oesophageal Junction CancerGastric Cancer
- Interventions
- First Posted Date
- 2011-10-24
- Last Posted Date
- 2017-03-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 960
- Registration Number
- NCT01457846
- Locations
- 🇬🇧
Research Site, Wolverhampton, United Kingdom
An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder
- Conditions
- Bipolar Disorder
- First Posted Date
- 2011-10-20
- Last Posted Date
- 2014-08-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 16000
- Registration Number
- NCT01455961
Effect of High Dose Ciclesonide on Asthma Control
- First Posted Date
- 2011-10-19
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 520
- Registration Number
- NCT01455194
Descriptive Pharmacoepidemiological Study of Patients Treated With Iressa
- Conditions
- Lung Cancer
- First Posted Date
- 2011-10-07
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 361
- Registration Number
- NCT01448187
- Locations
- 🇫🇷
Research Site, Vienne, France
🇫🇷Reseacrh Site, Metz, France
A Healthy Female and Male Volunteers Aspirin Study
- Conditions
- Healthy
- Interventions
- Drug: Capsule ASA 81mg/esomeprazole 20mgDrug: Acetylsalicylzuur Apotex Cardio
- First Posted Date
- 2011-10-07
- Last Posted Date
- 2012-05-10
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 54
- Registration Number
- NCT01448031
- Locations
- 🇬🇧
Research Site, London, UK, United Kingdom